300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oceania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Seychelles
Paraguay
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Canada
United Kingdom
Peru
San Marino
Slovenia
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Bausch & Lomb, VC Fund

Bausch & Lomb

VC Fund

Rochester, United States

Bausch & Lomb is a VC fund in Rochester focused on Health Care and Biotechnology. Bausch + Lomb is the eye health company dedicated to Bringing Visionary Ideas to Eye Health.They offer the world’s most comprehensive portfolio of eye health products, and They have one of the oldest, best known and most respected healthcare brands in the world.The company began in 1853 in Rochester, New York, as a small optical shop thatgrew to become a multi-billion dollar corporation with approximately 13,000 employees worldwide, and with products available in more than 100 countries.

Total investments:
7
Last investment:
Lead investor:
43%

Last updated:

Industries Bausch & Lomb invests in

Health CareBiotechnologyMedicalTherapeuticsMedical Device

Stages Bausch & Lomb invests in

GrantSeries BSeries DSeries GFunding Round

Countries Bausch & Lomb invests in

United States

Contacts

NameEmailPhoneSocials
Robert Bertolini Robert Bertolini
Bob Palmisano Bob Palmisano
Chad Speegle Chad Speegle
Joseph Landy Joseph Landy
See all 11 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Health Care 3 (43%)
  • Biotechnology 2 (29%)
  • Medical 1 (14%)
  • Therapeutics 1 (14%)
  • Medical Device 1 (14%)

Stage

  • Grant 1 (14%)
  • Series B 1 (14%)
  • Series D 1 (14%)
  • Series G 1 (14%)
  • Funding Round 1 (14%)
See all 7 stages →

Team

NameTitleInvestmentsLinksEmail
Brenton Saunders
Brenton Saunders Chief Executive Officer
Chief Executive Officer Total investments: 9
Find email
Robert Bertolini
Robert Bertolini President & CFO
President & CFO Total investments: 0 Find email
Bob Palmisano
Bob Palmisano Executive
Executive Total investments: 0 Find email
Chad Speegle
Chad Speegle Territory Manager
Territory Manager Total investments: 0 Find email
Joseph Landy
Joseph Landy Director
Director Total investments: 5 Find email
See all 11 team members →

Investments

CompanyDescriptionRoundLinks
Emmecell Emmecell
Emmecell is a biotechnology company that provides developing cell-based therapies. Corporate Round / Jun 16, 2026
Character Biosciences Character Biosciences
Biopharmaceutical research and development company that's an affiliate of Clover Health $93M / Series B / Mar 25, 2025
The Seeing Eye The Seeing Eye
The Seeing Eye is a donation based company that trains and provides seeing eye canines alongside owner training for blind individuals. $25K / Grant / Mar 18, 2024
AcuFocus AcuFocus
Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons onsurgical placement of the KAMRA.It was founded in 2011 and headquartered in Irvine, California. $21M / Sep 03, 2014
AcuFocus AcuFocus
Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons onsurgical placement of the KAMRA.It was founded in 2011 and headquartered in Irvine, California. $21M / Series G / Sep 03, 2014
AcuFocus AcuFocus
Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons onsurgical placement of the KAMRA.It was founded in 2011 and headquartered in Irvine, California. $65M / Private Equity / Nov 29, 2011
AcuFocus AcuFocus
Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons onsurgical placement of the KAMRA.It was founded in 2011 and headquartered in Irvine, California. $18M / Series D / Jan 26, 2007

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oceania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Seychelles
Paraguay
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Canada
United Kingdom
Peru
San Marino
Slovenia
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Bausch & Lomb invest in?

Bausch & Lomb invests primarily in Health Care, Biotechnology and Medical startups, most often at Grant and Series B stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Bausch & Lomb?

Public channels for Bausch & Lomb include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Bausch & Lomb?

The team at Bausch & Lomb includes Brenton Saunders (Chief Executive Officer), Robert Bertolini (President & CFO) and Bob Palmisano (Executive), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Bausch & Lomb Bausch & Lomb Find emails